Literature DB >> 8527470

Becker-like muscular dystrophy in sisters.

P Diószeghy1, M Molnár, F Mechler.   

Abstract

Two sisters with muscular dystrophy of Becker-like clinical features presented. Muscle weakness was most prominent in the pelvic girdle, but in the elder sister the distal muscles of the lower extremities were also affected. The progression was different in the siblings: The older sister showed a more pronounced deterioration than the younger. The family history was negative in four generations including their brother and youngest sister. Serum creatinine kinase activities increased considerably. Electromyogram and muscle biopsy specimens revealed myopathic changes characteristic of muscular dystrophy. Chromosomal analysis confirmed normal 46,XX karyotype. DNA analysis with all cDNA probes spanning the entire dystrophin gene failed to reveal any intragenic deletion or duplication on southern blot. Immunohistochemistry for dystrophin using monoclonal antibodies against the rod and C-terminal domains showed normal continuous staining at the sarcolemma of the muscle fibers in the biopsy specimens of both patients. The results practically exclude the possibility of Xp21 myopathy, and it seems reasonable to classify these patients as having autosomal recessive childhood muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527470     DOI: 10.1007/bf02191875

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  20 in total

1.  Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy.

Authors:  K Arahata; T Ishihara; K Kamakura; T Tsukahara; S Ishiura; C Baba; T Matsumoto; I Nonaka; H Sugita
Journal:  N Engl J Med       Date:  1989-01-19       Impact factor: 91.245

2.  The manifesting carrier in Duchenne muscular dystrophy.

Authors:  H Moser; A E Emery
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

3.  Severe childhood muscular dystrophy affecting both sexes and frequent in Tunisia.

Authors:  M Ben Hamida; M Fardeau; N Attia
Journal:  Muscle Nerve       Date:  1983-09       Impact factor: 3.217

4.  Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses.

Authors:  K Arahata; E P Hoffman; L M Kunkel; S Ishiura; T Tsukahara; T Ishihara; N Sunohara; I Nonaka; E Ozawa; H Sugita
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy.

Authors:  E Bonilla; B Schmidt; C E Samitt; A F Miranda; A P Hays; A B de Oliveira; H W Chang; S Servidei; E Ricci; D S Younger
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

6.  Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy.

Authors:  C S Richards; S C Watkins; E P Hoffman; N R Schneider; I W Milsark; K S Katz; J D Cook; L M Kunkel; J M Cortada
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

7.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

8.  Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy.

Authors:  K Matsumura; F M Tomé; H Collin; K Azibi; M Chaouch; J C Kaplan; M Fardeau; K P Campbell
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

9.  Severe autosomal recessive muscular dystrophy in an extended Sudanese kindred.

Authors:  M A Salih; M I Omer; R A Bayoumi; O Karrar; M Johnson
Journal:  Dev Med Child Neurol       Date:  1983-02       Impact factor: 5.449

10.  Dystrophin analysis in the diagnosis of muscular dystrophy.

Authors:  A M Norman; H E Hughes; D Gardner-Medwin; L V Nicholson
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.